F.lli Ferrari Holding, ultimately owned by Mutares SE & Co. KGaA, has signed an agreement for the partial sale of its Netherlands distribution business to HMF Group. The transaction is expected to close in early June 2026, subject to customary closing conditions. The divested business generates approximately...
Lupin Limited announced that it has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g. The approved product is bioequivalent to the reference...
Rio Tinto announced that it has successfully started commissioning its $1.5 billion AP60 smelter expansion at Complexe Arvida in Quebec. This marks a significant milestone in deploying its state-of-the-art, low-carbon aluminium smelting technology. The start-up, which began in March, is expected to be...
Universal Music Group N.V. (UMG.AS, UNVGY, UMGNF), the Dutch-American music-based entertainment company, announced that its Board of Directors has unanimously determined that the unsolicited and non-binding proposal received from Pershing Square Capital Management, L.P. on April 7, 2026, is not in the...
Johnson & Johnson (JNJ) announced updated findings from the Phase 1/1b CHRYSALIS-2 study, which evaluated intravenous RYBREVANT (amivantamab-vmjw) in combination with LAZCLUZE (lazertinib) in patients with advanced non-small cell lung cancer (NSCLC) harboring atypical epidermal growth factor receptor...
Lundin Mining Corporation (LUN.TO) announced an update to its share capital and voting rights. As of May 29, 2026, the number of issued and outstanding shares decreased by 231,484, bringing the total to 855,378,907 common shares with voting rights. This reduction reflects share buybacks completed under...
Friday, Lanvin Group Holdings Limited (LANV) announced that its couture house in Paris, Maison Lanvin, has appointed Barbara Werschine as Chief Executive Officer. Most recently, Werschine served as CEO of Eric Bompard, where she successfully modernized the brand and optimized its financial performance. Upon...
Dizal (688192.SS) announced the results from the phase 3 WU-KONG28 study showing that ZEGFROVY monotherapy demonstrated superior anti-tumor efficacy, compared to platinum-doublet chemotherapy, in untreated NSCLC patients with EGFR exon 20 insertion mutations. Xiaolin Zhang, CEO of Dizal, said: "WU-KONG28...
The Bank Of Nova Scotia (BNS, BNS.TO) said on Friday that it has inked a deal to acquire Maple Financial Holdings, Inc., parent company to MapleMark Bank. Travis Machen, CEO and Group Head, Global Banking and Markets, Scotiabank, said: "Our acquisition of MapleMark Bank allows Scotiabank to offer...
Johnson & Johnson (JNJ) on Friday reported new positive results from the Phase 3 MajesTEC-9 study evaluating TECVAYLI in patients with relapsed or refractory multiple myeloma treated as early as second line. The study showed that treatment with TECVAYLI reduced the risk of disease progression or death...
Friday, AbbVie Inc. (ABBV) announced that the European Commission has authorized an expanded label for VENCLYXTO to include use in combination with acalabrutinib and use in combination with ibrutinib for the treatment of adult patients with previously untreated chronic lymphocytic leukemia. The expanded...
CoStar Group (CSGP), a provider of online real estate marketplaces said on Friday it agreed to buy Zonda, a provider of new home construction data and marketplaces, for $800 million in cash. The deal is expected to close in the second half of 2026 and be accretive to adjusted earnings per share in...
Pfizer Inc. (PFE) on Friday reported seven-year follow-up results from the Phase 3 CROWN trial showing that LORBRENA significantly improved progression-free survival compared with XALKORI in patients with previously untreated ALK-positive advanced or metastatic non-small cell lung cancer. At seven...
Tempus AI (TEM) announced the FDA has granted approval for a tumor-only indication for its xT CDx next-generation sequencing platform. The company noted that, with the expanded label, Tempus is the first laboratory to hold FDA companion diagnostic approval for both tumor-only and tumor-normal comprehensive...
Friday, Agios Pharmaceuticals, Inc. (AGIO) announced its decision to discontinue the study of tebapivat, a next-generation oral pyruvate kinase activator designed to provide optimized clinical benefits for patients with rare hematologic diseases. The decision comes as results from its Phase 2b trial...
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.